国产酒店约孕妇高潮在线观看_狼友av永久网站免费观看武_亚洲日产无码中文字幕在线_日本三级片亚洲

Corporate News: Successful Approval of CEP Certificate for Lidocaine Hydrochloride API by EDQM

Chenghui Shuangda 11

On November 10, 2025, our company successfully obtained approval for the European CEP registration of our active pharmaceutical ingredient (API), Lidocaine Hydrochloride. We have received the Certific...

Shandong Chenhui Pharmaceutical Group Shines at CPHI Worldwide Europe 2025

Chenghui Shuangda 17

From October 28th to 30th, 2025, Shandong Chenhui Pharmaceutical Group made a remarkable appearance at the CPHI Worldwide Europe exhibition in Frankfurt, Germany. This premier industry event brought ...

Shandong Chenghui Pharma Group Invites You to Visit Booth A5011 at Pharmtech & Ingredients 2025

Chenghui Shuangda 20

Achinery Exhibition (Pharmtech & Ingredients) will be held at the Crocus Expo IEC in Moscow. Shandong Chenghui Pharmaceutical Group will showcase its core products and technical solutions ...

Join Shandong Chenghui Pharmaceutical Group at API China 2025 – Booth 5M22, Hall 5N

Chenghui Shuangda 16

From November 12th to 14th, 2025, the 93rd China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Trade Fair (API China) will grandly open at the Chongqing International E...

EDQM Certifies Lidocaine CEP: A Milestone for International Expansion

Chenghui Shuangda 22

?On October 9, 2025, our company's active pharmaceutical ingredient (API) ?Lidocaine? received approval for its ?European CEP (Certificate of Suitability to the European Pharmacopoeia)? registration ...

CPHI Europe 2025 Preview: Connect Globally at Chenghui Shuangda’s Booth 12.0F108!

Chenghui Shuangda 47

Mark your calendars! The premier gathering for the global pharmaceutical industry—CPHI Worldwide Europe 2025—will take place from October 28 to 30, 2025 at the iconic Messe Frankfurt exhibition c...

Shandong Chenghui Shuangda Pharma Achieves Resounding Success at Pharmaconex 2025 in Cairo

Chenghui Shuangda 47

September 2025, Cairo – As a regional industry cornerstone, the exhibition significantly strengthened our brand influence in the Middle East and African markets. The camera captures moments, whi...

Approval Announcement | Shandong Chenghui Shuangdas Topical API Crisaborole Successfully Upgraded to Category A

Chenghui Shuangda 80

【Breaking News】Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.'s independently developed active pharmaceutical ingredient (API) Cliborol (Registration No.: Y20230000985) received approval from th...

Pioneering Milestone: Chinas First CEP Certification for Tetracaine HCl API Granted by EDQM

Chenghui Shuangda 108

We are proud to announce that our pharmaceutical ingredient Tetracaine Hydrochloride has been granted the Certificate of Suitability to the European Pharmacopoeia (CEP) by the European Directorate fo...

CPHI & PMEC Shenzhen 2025: Shandong Chenghui Pharma Showcases Cutting-Edge Solutions at Booth 9L39

Chenghui Shuangda 54

Shandong Chenghui Pharma Group cordially invites you to attend CPHI & PMEC Pharmaceutical Industry Exhibition (Shenzhen), which will be held grandly at Shenzhen Convention and Exhibition Center from ...